BCR-ABL expression is presumed to effect clonal expansion in chronic myeloid leukemia (CML) by deregulation of cell Proliferation. However, most studies have found that relative rates of cell proliferation are not increased in CML. Moreover, we found that CML progenitors display a normal proliferative response to growth factors and do not manifest greater proliferative potential than normal progenitors. Growth of malignancies depends on an imbalance between the rate of cell production and the rate of cell death. We found that BCR-ABL expression inappropriately prolongs the HRONIC MYELOID leukemia (CML) is a hematologic malignancy characterized by an initial chronic phase of expanded clonal hematopoiesis with continued differentiation into mature myeloid cells. The Philadelphia chromosome (Ph), t(9;22), is the cytogenetic hallmark of CML'.'; this balanced translocation results in the creation of a chimeric BCR-ABL gene that expresses an 8.5-kb hybrid mRNA transcript and a 210-kD fusion protein (P210BCR-ABL).3,4 The mechanism of deregulated cell growth in CML has not been defined. BCR-ABL expression is presumed to effect clonal expansion in CML by deregulation of cell proliferation. However, although some investigators have reported that the fraction of actively cycling CML progenitors is higher than most studies have found that relative rates of cell proliferation are not increased in CML.7"' Furthermore, CML progenitors display a normal proliferative response to growth factors," and the induction of P210 expression is alone unable to generate growth factor-independent proliferation of hematopoietic progenitors."
growth factor-independent survival of CML myeloid progenitors and granulocytes by inhibiting apoptosis, a genetically programmed process of active cell death; inhibition of BCR-ABL expression by antisense oligonucleotides reversed the suppression of apoptosis as well as the enhancement of survival. The decreased rate of programmed cell death appears to be the primary mechanism by which BCR-ABL effects expansion of the leukemic clone in CML. 0 1994 by The American Society of Hematology.
MATERIALS AND METHODS

Cell lines. Studies were performed on two interleukin-3 (IL-3)-dependent murine cell lines, Ba-F3 (early B-lineage)" and FDC-PI (myeloid).'* The cell lines induced to constitutively express P210
by retroviral infection with a full-length BCR-ABL cDNA sequence were provided by R.A. Van Etten and D. Baltimore (Ba-F3Pz"')'9 and S. Cory (FDC-PlPz'").2" The cell lines were maintained in complete (containing vitamins, amino acids, and lipids) serum-free media (Serum-Free and Protein-Free Hybridoma Medium; Sigma, St Louis, MO) in 5% COz at 37°C with 100 U murine recombinant IL-3 (or 10% WEHI-conditioned medium as a source of IL-3) added to the parental cell lines.
Isolation of hematopoietic cells. Bone marrow cells from posterior iliac crest aspiration and peripheral blood cells were obtained from 5 patients with chronic-phase CML and 5 normal volunteers after informed consent approved by the Joint Committee on Clinical Investigation of the Johns Hopkins Medical Institutions. Granulocytes were isolated from peripheral blood by sequential density centrifugation using Ficoll-Hypaque of specific gravity 1.077 followed by specific gravity 1. I 19 as described.?' Bone marrow mononuclear cells (density, < I .077) were also recovered by Ficoll-Hypaque density centrifugation. CD34' cells were selected from plastic nonadherent mononuclear marrow cells, treated with anti-CD34 monoclonal antibody, and recovered by indirect immune adherence.I2
Inhibition of BCR-ABL expression by antisense oligonucleotides. Cells were cultured in serum-free media at 37°C and 5% CO2. Treatment of Ba-F3P2'0 cells with BCR-ABL junction specific antisense oligonucleotides showed that BCR-ABL expression was still apparent after 6 hours of exposure at all concentrations tested (Fig I) . Optimal inhibition of BCR-ABL expression was seen after 12 hours of exposure to 15 pmoI/L antisense oligonucleotides; a concentration of 5 pmol/L had no effect and 10 pmol/L produced only a partial effect. BCR-ABL junction-specific antisense and nonsense oligonucleotides (18 bases) were therefore added at a concentration of 15 pmol/L at the start of culture. Oligonucleotides were again added at IO pmoVL 12 hours later for the cell lines, 18 hours later for the granulocytes, and 24 and 48 hours later for the CD34' cells. The following oligonucleotide sequences were usedzg: b,az antisense, 5'-GAAGGGCTTTTGAACTCT-3'; bzaz antisense, 5"GAAGGGCTT-CTTCCTTAT-3'; bgaz 2 nucleotide substitution nonsense, 5'-GAA-GTGCTGTTGAACTCT-3'; and bzaz 4 nucleotide substitution nonsense, 5'-GAACGGCATCTACGTTAT-3'.
Cell cultures. Granulocyte-macrophage colony-forming units (CFU-GM) were cultured from bone marrow mononuclear cells or CD34' cells by seeding lo5 marrow mononuclear cells or 5 X 10' CD34' cells into quadruplicate l-mL methylcellulose (1.32%) CUItures containing 30% fetal calf serum, 1% bovine serum albumin, and 10" molL 2-mercaptoethanol as we previously described.zJ Either granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-3, or 10% phytohemagglutinin-stimulated leukocyte-conditioned medium (PHA-LCM) was used as the stimulating factor. Colonies (an aggregate of 40 or more cells) were scored with an inverted microscope after 14 days of incubation at 37°C and 5%
cot.
Flow cytometric analysis of cell cycle distribution and apoptosis. Cells were fixed in 50% ethanol, permeabilized with 0.1% Triton-X-100, treated with 5 &mL RNAse, and incubated at 37°C for 15 minutes before staining with 50 &mL propidium iodide for 60 minutes at 4°C. The fraction of subdiploid cells with oligonucleosomal DNA degradation characteristic of apoptosis," and the fraction of residual viable cells (excluding the subdiploid fraction) in the GB/ G , and S/G2M phases of the cell cycle was quantified by flow cytometric analysis (FACscan; Becton Dickinson, Mountain View, CA). The results from the cell cycle analyses are the mean 2 SEM of three experiments for the cell lines and the mean 2 SEM from the 5 CML patients and 5 normals.
Gel electrophoresis for detection of oligonucleosomal DNA fragments. Cells (5 X IO5) were recovered from incubations of CML or normal granulocytes in serum-free medium for analysis of oligonucleosomal DNA fragmentation. DNA was isolated after sodium dodecyl sulfate (SDS) lysis and proteinase K digestion as previously described.26 DNA fragments were separated by agarose gel (2%) electrophoresis~' and oligonucleosomal bands were visualized by staining with ethidium bromide. Control for size of DNA fragments were 100-bp DNA size markers (GIBCO BRL, Gaithersburg, MD). Polymerase chain reaction (PCR) amplification of BCR-ABL mRNA. We used our previously described procedure with minor modifications?* Total RNA was prepared from 104 cells of each sorted subpopulation by the method of Belyavsky et a]?' First strand DNA was synthesized with Moloney murine leukemia virus (MMLV) reverse transcriptase, buffers, and conditions described by Bethesda Research Laboratories (BRL; Gaithersburg, MD) using 2 ng random hexanucleotides (Pharmacia, Uppsala, Sweden) as primer?' in the presence of 4 U RNasin (Promega, Madison, WI). Random hexanucleotide primers ensured efficient cDNA synthesis necessary for PCR amplification to be sensitive and reproducible. This cDNA product was divided for two PCRs: one with CML-specific primers" added and one with P-actin-specific primers"' added. The following oligonucleotide primers were used: bcr 5' sense primers: CML A, S'GGAGCTGCAGATGCTGACCACC 3'; ab1 3' antisense primers: CML B, 5'TCAGACCCTGAGGCTCAAAGTC 3'; 0-actin primers: 5' primer, 5'-GACGAGGCCCAGAGCAAGAG-3', and 3' primer, 5'-GGGCCGGACTCATCGTACTC-3'. The P-actin primers were designed to span introns to avoid amplification of DNA that could contaminate the RNA preparations. PCR buffer has been described" and 2 U of Amplitaq (Perkin Elmer, Cetus, Nonvalk CT) was added.
A Coy tempcycler (Model 50; Coy Laboratory Products Inc. Grass Lake, MI) was used with the following program: 5 minutes at 95°C; 40 cycles of 1 minute at 95°C. 30 seconds at 65°C. and I minute at 72°C; and one final 72°C extension for 5 minutes. BCR-ABL PCR products were analyzed by electrophoresis, transfer, and hybridization to end-labeled (5' End Labelling System; Dupont NEN, Boston, MA) BCR-ABL junction-specific oligonucleotide probes complementary to the b,az splice (CML C; 5'GCTGAAGGGCTTTTG-AACTCTGCTTA 3') or b2az splice (CML D; S'GCTGAAGGGCITClTCC lTATTGATG3') to assure specificity of PCR for BCR-ABL beyond the mobility of the PCR product on the gel."
RESULTS
We studied the effect of P210 expression on the growth and survival of the two IL-3-dependent cell lines, Ba-F3 and FDC-P1. Constitutive expression of P210 results in factorindependent growth of both cell Factor-dependent cell lines suffer apoptotic cell death when deprived of cytokines.I4 Ba-F3 cells rapidly died after IL-3 withdrawal (Fig  2) . Within 12 hours of IL-3 withdrawal, there was clear evidence of oligonucleosomal DNA degradation characteristic of apoptosis, as detected by gel electrophoresis (not shown) and by flow cytometry (Fig 3) . In contrast, Ba-F3PZ'" maintained a viability of 90% 2 3% at 18 hours after IL-3 withdrawal (Fig 4A) , with no evidence of apoptosis at 12 hours (Fig 3) . BCR-ABL antisense oligonucleotides have been shown to effectively inhibit P210 expressionz3; we confirmed the inhibition of BCR-ABL expression by this antisense strategy using reverse transcriptase-PCR (RT-PCR) for the detection of BCR-ABL mRNA (Fig 1) . Inhibition of P210 expression by antisense oligonucleotides complementary to BCR-ABL mRNA reversed the enhanced survival (Fig 4A) and the suppression of apoptosis (Fig 3) seen in the Ba-F3=''; IL-3 treatment prevented the apoptotic death of the Ba-F3PZ10 cells incubated with BCR-ABL antisense oligonucleotides (Fig 4B) . Exposure of parental Ba-F3 cells (Fig 4B) and the mouse lymphoid cell line L1210 (that does not express P210) to BCR-ABL antisense oligonucleotides had no effect on cell survival or growth. Parental FDC-PI cells and those expressing P210 behaved similarly to their Ba-F3 counterparts (data not shown).
Although IL-3 deprivation initiated apoptotic cell death, residual viable Ba-F3 cells continued to progress through the cell cycle (Fig 3) , as previously dem~nstrated.~~ Furthermore, after IL-3 deprivation, total Ba-F3 cell numbers (viable and nonviable) continued to increase, whereas the number of viable cells declined (Fig 2) . Therefore, Ba-F3 cells appeared capable of IL-3-independent proliferation, although the addition of IL-3 may augment the proliferation of these cells. The growth of a cell population requires not only a proliferative stimulus but also a signal for cell survival; loss of the necessary survival signal provided by IL-3 inhibited the growth of Ba-F3 cells. Most importantly, we found inhibition of BCR-ABL-expression by antisense oligonucleotides did not alter the cell cycle distribution of residual, viable Ba-F3P2'o cells; the fraction of residual viable cells in the S + G2/M phases of the cell cycle was 36% 2 2% after treatment with nonsense oligonucleotides for 12 hours, when apoptotic death was well established (Fig 3) . Moreover, total cell numbers in the BCR-ABL antisense cultures also continued to increase, whereas viable cell numbers rapidly declined (Fig 4A) . Thus, P210 substitutes for the necessary survival signal normally provided by IL-3.
We also studied the effect of P210 expression on hematopoietic cells from 5 patients with Ph-positive chronic-phase CML. The effect of P210 expression on survival distinct from proliferation was analyzed by comparing the survival of terminally differentiated peripheral blood granulocytes from the CML patients and from 5 normal donors. Cell cycle analysis indicated the absence of actively cycling cells in this population from both the normals and CML patients (Fig 5) . Only 8% 2 1% of normal granulocytes remained viable after 48 hours in serum-free media (Fig 6) . DNA fragmentation characteristic of apoptosis was apparent at 4 hours and became extensive at 8 hours (Fig 7) . In contrast, CML granulocytes were 85% +-4% viable after 48 hours in serum-free media (Fig 6) . Gel electrophoresis showed no evidence of apoptosis at 8 hours and minimal DNA fragmentation at 18 hours (Fig 7) . There are two possible types of BCR-ABL mRNA transcribed in CML as a result of alterna- tive splicing that either includes BCR exon 3 (b3a2) or excludes BCR exon 3 (b2a2).3s The specific BCR-ABL transcript expressed in each patient was determined by RT-PCR with hybridization of the PCR product to BCR-ABL junction-specific oligonucleotide probes for the b3az or bza2 splice. Inhibition of P210 expression by antisense oligodeoxynucleotides, complementary to the specific BCR-ABL mRNA (b3a2 or b2a2) expressed in each patient, reversed the extended survival of the CML granulocytes; nonsense oligonucleotides had no effect on their survival (Fig 6) . Antisense oligonucleotides specific for the alternative type of BCR-ABL transcript (not expressed in that CML patient) also had no effect on granulocyte survival.
To assess the effect of P210 expression on cell proliferation, we compared the proliferative ability of CML and normal myeloid progenitors. CML CFU-GM displayed a doseresponse to GM-CSF (Fig 8A) and IL-3 ( Fig 8B) Gel electrophoresis for detection of oligonucleosomal DNA fragments after 4,8, and 18 hours of culture in serum-free medium. As a negative control for apoptosis, normal granulocytes were also incubated with 100 UlmLof GM-CSF (GF). As previously described." GM-CSF prevented apoptosis of the normal granulocfles. Lane C depicts 100-bp DNA size markers.
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From native type of BCR-ABL transcript had no effect on their 100 survival. 80 We found that the cell cycle distribution and frequency 60 of CML bone marrow progenitors is similar to that of normal (23% ? 1% v 26% 2 2%) and CD34+ cells (19.3% ? 0.2% v 20.2% 2 0.2%) in the S +G2M phases of the cell cycle were similar in CML patients and normals, respectively. Hence, CML progenitors do not exhibit greater proliferative potential than normal progenitors and display a normal proliferative response to growth factors. To determine whether CML progenitors also show enhanced cell survival, we compared the survival of CML and normal myeloid progenitors. Only 22% 2 3% of normal CD34+ bone marrow cells were viable after 96 hours in serum-free media, whereas 65% 2 3% of CML CD34' cells remained viable after 96 hours in serum-free conditions ( Fig   9A) . Because no proliferation of normal or CML CFU-GM occurred in the absence of growth factors, the fraction of CFU-GM remaining after incubation in serum-free media is another index of progenitor survival. Normal CD34' cells showed extensive loss of CFU-GM in serum-free media, with 12% 2 2% residual colony-forming ability at 48 hours (Fig 9B) . In contrast, CML CD34+ cells maintained 84% +-8% colony-forming ability after 48 hours in serum-free conditions. Inhibition of BCR-ABL expression by antisense oligonucleotides reversed the enhanced survival of CML CD34' cells ( Fig 9A) and CFU-GM (Fig 9B) . Exposure of CML CD34+ cells to either nonsense oligonucleotides ( Fig  9A and B) or antisense oligonucleotides specific for the alter- For
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The P2lO-expressing cell lines proliferated in the absence of growth factor, whereas factor-dependent cell lines induced to overexpress the survival signal bcl-2 have been reported to show prolonged survival but arrest in Go/GI when deprived of growth factor.I6 These data might suggest that P210 also provides an important proliferative stimulus to these cells. However, after inhibition of P210 expression by antisense oligonucleotides, residual viable Ba-F3PZ10 and FDCp1P210 cells continued to proliferate even as apoptotic death simultaneously occurred within the population. Likewise, although IL-3 deprivation induced apoptosis of the IL-3-dependent parental cell lines, the residual viable cells continued to progress through the cell cycle and divide. Moreover, recent reports indicate that some factor-dependent cell lines induced to overexpress bcl-2 continue to proliferate after withdrawal of growth Therefore, neither BCR-ABL nor bcl-2 appear to have major effects on proliferation; whether cell lines expressing P210 or bcl-2 proliferate in the absence of growth factors is probably determined by other pre-existing or secondarily acquired genetic alterations. Similarly, hematopoietic cells induced to express P210 have been shown to remain dependent on growth factors for proliferation for protracted periods; the subsequent acquisition of factor-independence in some subclones was not associated with any change in BCR-ABL expression.13
Inhibition of apoptosis may be the biologic explanation for the similarity between the clinical syndromes produced by BCR-ABL (CML) and bcl-2 (follicular lymphoma). Both CML and follicular lymphoma exhibit an initial indolent phase with uninterrupted differentiation. The neoplastic clone in each disorder is characterized by an intrinsic genomic instability with the progressive accumulation of secondary genetic alterations that invariably lead to the development of aggressive malignant phenotypes (blast crisis in CML and high-grade lymphoma from follicular lymphoma). Aberrant cell survival resulting from suppressed apoptosis may allow cells to accumulate secondary genetic changes that lead to neoplastic progression. CML and follicular lymphoma are also both incurable with conventional doses of chemotherapy. Many cytotoxic agents produce cell death by inducing apopt~sis.~' The cellular susceptibility to cytotoxic agents can be influenced by various genetic factors that regulate apoptosis; bcl-2 expression protects cells from multiple cytotoxic agent^.'^.^' Thus, inhibition of apoptosis by BCR-ABL may play an important role in clonal expansion, tumor progression, and resistance to cytotoxic therapy in CML.
